Golaz A, Hardy I R, Strebel P, Bisgard K M, Vitek C, Popovic T, Wharton M
Child Vaccine Preventable Disease Branch, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA.
J Infect Dis. 2000 Feb;181 Suppl 1:S237-43. doi: 10.1086/315569.
The re-emergence of diphtheria in the Newly Independent States of the former Soviet Union in the 1990s raised global awareness of the potential for resurgent disease in countries with long-standing immunization programs. In the United States, the large population of susceptible adults and the possibility of a reintroduction of toxigenic strains of diphtheria create a setting in which diphtheria could spread. In addition, at least one focus of continued circulation of endemic toxigenic Corynebacterium diphtheriae has been identified. Few physicians now have expertise in the diagnosis and treatment of persons with diphtheria, and laboratory capacity is lacking throughout the country. These concerns highlight the importance of maintaining high levels of age-appropriate diphtheria toxoid vaccination, surveillance, accessible and reliable laboratory testing, and training of health care providers. Although the risk of resurgence of diphtheria in the United States is low, public health authorities must ensure that the capacity to recognize, diagnose, and control diphtheria is maintained.
20世纪90年代,前苏联新独立国家白喉疫情的再度出现,提高了全球对长期实施免疫规划国家中疾病复发可能性的认识。在美国,大量易感成年人以及白喉产毒株重新传入的可能性,营造了白喉可能传播的环境。此外,已发现至少有一个地方存在产毒白喉棒状杆菌持续传播的疫源地。现在很少有医生具备诊断和治疗白喉患者的专业知识,而且全国缺乏实验室检测能力。这些担忧凸显了维持高水平的适龄白喉类毒素疫苗接种、监测、可及且可靠的实验室检测以及对医护人员进行培训的重要性。尽管美国白喉复发的风险较低,但公共卫生当局必须确保维持识别、诊断和控制白喉的能力。